NCT00835939|UnknownPhase 2/3DMC
Loading search results
Sponsor study identifier
interventional
17
1 country
1
Study Start
September 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
Not reported
Date not reportedThe purpose of this study is to determine whether sclerotherapy using a 25% dextrose and 1% lidocaine solution is an efficacious treatment for patients with chronic Achilles tendinopathy who have failed a home based, heavy load eccentric training program.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2007
Date type not reportedThis date has not been verified as actual or estimated.
February 3, 2009
Actual (reported)February 4, 2009
Actual (reported)January 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Victorian Institute for Sport Assessment - Achilles
Baseline, 4 weeks, 8 weeks, 12 weeks, 6 months, 1 year
100 mm Visual Analog Scale
Baseline, 4 weeks, 8 weeks, 12 weeks, 6 months, 1 year
Tegner Activity Scale
Baseline, 4 weeks, 8 weeks, 12 weeks, 6 months, 1 year
Number of Neovessels
Up to 3 injections provided to neovessels outside of the tendon
Up to 3 injections provided to neovessels outside of the tendon
University of Calgary
Calgary, Alberta, T2N 1N4, Canada
J Preston Wiley, MD, MPE
University of Calgary
17 participants (actual enrollment reported by the registry).
First Submitted
February 3, 2009
First Posted
February 4, 2009
Study Start
September 2007
Date type not reportedThis date has not been verified as actual or estimated.
Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief
Baseline, 4 weeks, 8 weeks, 12 weeks
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
January 2010
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 4, 2009
Record last verified: 2009-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: